pulmatrix pipeline

Pulmatrix is developing a broad pipeline to prevent and treat a range of respiratory diseases which have considerable unmet medical need. Disease applications for iSPERSE therapies include chronic respiratory diseases such as COPD, asthma, bronchiectasis, idiopathic pulmonary fibrosis and cystic fibrosis.  The company has developed an integrated capability to take projects from concept through early stage formulation development, preclinical evaluation, CMC scale up, non-clinical safety testing, CMO transfer for clinical supply production, and clinical operations through Phase II.  These capabilities make Pulmatrix a one-stop innovation center for development of inhaled dry powder therapeutics through clinical proof of concept.